Search Result "PI3K/ERK"
EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell MalignantNeural Invasion via Activation of PI3K/AKT and MEK/ERK Signaling
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 7 Year: 2022 Page: 603-616
Author(s):
Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments
Journal: Current Signal Transduction Therapy
Volume: 4 Issue: 2 Year: 2009 Page: 130-143
Author(s): Ludovica Ciuffreda, James A. McCubrey, Michele Milella
Low Dose of Acacetin Promotes Breast Cancer MCF-7 Cells Proliferation Through the Activation of ERK/ PI3K /AKT and Cyclin Signaling Pathway
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 3 Year: 2018 Page: 368-377
Author(s): Huanhuan Ren,Jun Ma,Lingling Si,Boxue Ren,Xiaoyu Chen,Dan Wang,Wenjin Hao,Xuexi Tang,Defang Li,Qiusheng Zheng
Caffeine Effect on HIFs/VEGF Pathway in Human Glioblastoma Cells Exposed to Hypoxia
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 10 Year: 2018 Page: 1432-1439
Author(s): Grazia Maugeri,Agata G. D'Amico,Daniela M. Rasà ,Salvatore Saccone,Concetta Federico,Gaetano Magro,Sebastiano Cavallaro,Velia D'Agata
Adipocytes Contribute to Resistance of Human Melanoma Cells to Chemotherapy and Targeted Therapy
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 10 Year: 2014 Page: 1255-1267
Author(s): M. Chi,J. Chen,Y. Ye,Hsin-Yi Tseng,F. Lai,K.H. Tay,L. Jin,S.T. Guo,C.C. Jiang,X.D. Zhang
Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer
Journal: Current Genomics
Volume: 12 Issue: 8 Year: 2011 Page: 597-608
Author(s): Jose M. Gomez Saez
Dysfunction in Brain-Derived Neurotrophic Factor Signaling Pathway and Susceptibility to Schizophrenia, Parkinsonâs and Alzheimerâs Diseases
Journal: Current Gene Therapy
Volume: 18 Issue: 1 Year: 2018 Page: 45-63
Author(s): Alireza Mohammadi,Vahid Ghasem Amooeian,Ehsan Rashidi
Targeting Protein Kinase Inhibitors with Traditional Chinese Medicine
Journal: Current Drug Targets
Volume: 20 Issue: 15 Year: 2019 Page: 1505-1516
Author(s): Yangyang Zhang,Minghua Liu,Jun Wang,Jianlin Huang,Mingyue Guo,Ling Zuo,Biantiao Xu,Shousong Cao,Xiukun Lin
Morpholine: Pharmacophore Modulating Pharmacokinetic Properties of Anticancer Leads
Ebook: Key Heterocyclic Cores for Smart Anticancer DrugâDesign Part II
Volume: 2 Year: 2022
Author(s):
Doi: 10.2174/9789815040043122020008
Transactivation of ErbB Receptors by Leptin in the Cardiovascular System: Mechanisms, Consequences and Target for Therapy
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 616-624
Author(s): Jerzy Beltowski,Anna Jazmroz-Wisniewska